Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 May 15.
Published in final edited form as: Biochem Pharmacol. 2007 Jan 30;73(10):1613–1621. doi: 10.1016/j.bcp.2007.01.033

Glutathione Depletion and Recovery After Acute Ethanol Administration in the Aging Mouse

Barbara L Vogt 1,*, John P Richie Jr 1
PMCID: PMC1930162  NIHMSID: NIHMS21948  PMID: 17343832

Abstract

Glutathione (GSH) plays an important role in the detoxification of ethanol (EtOH) and acute EtOH administration leads to GSH depletion in the liver and other tissues. Aging is also associated with a progressive decline in GSH levels and impairment in GSH biosynthesis in many tissues. Thus, the present study was designed to examine the effects of aging on EtOH-induced depletion and recovery of GSH in different tissues of the C57Bl/6NNIA mouse. EtOH (2-5 g/kg) or saline was administered i.p. to mice of ages 6 mo (young), 12 mo (mature), and 24 mo (old); and GSH and cyst(e)ine concentrations were measured 0-24 hours thereafter. EtOH administration (5g/kg) depleted hepatic GSH levels >50% by 6 hr in all animals. By 24 hr, levels remained low in both young and old mice, but recovered to baseline levels in mature mice. At 6 hr, the decrease in hepatic GSH was dose-dependent up to 3 g/kg EtOH, but not at higher doses. The extent of depletion at the 3 g/kg dose was dependent upon age, with old mice demonstrating significantly lower GSH levels than mature mice (P<0.001). Altogether these results indicate that aging was associated with a greater degree of EtOH and fasting-induced GSH depletion and subsequent impaired recovery in liver. An impaired ability to recover was also observed in young animals. Further studies are required to determine if an inability to recover from GSH depletion by EtOH is associated with enhanced toxicity.

Keywords: ethanol, aging, glutathione, mouse

Introduction

Ethanol (EtOH) abuse in the elderly is an important public health concern [1-3]. Indeed, it has been estimated that as high as 45% of persons over age 60 have problems related to EtOH consumption [4]. The magnitude of this problem is compounded by the rapidly increasing proportion of the population represented by the elderly [5]. In addition, sensitivity of elderly subjects to the toxic effects of EtOH appears to be enhanced compared to younger persons [6-9]. Laboratory animal studies have also indicated that ethanol metabolism is decreased and toxicity increased with advancing age [10-13].

While little is known about the biochemical mechanisms responsible for the enhanced sensitivity to EtOH during aging, depletion of glutathione (GSH) may be involved based on its important role in detoxification of EtOH [14]. Hepatic GSH levels are depleted 6 hr after acute EtOH administration in young animals [14-17]. Further, when GSH levels are depleted prior to ETOH administration, an increase in toxicity is observed [18]. On the other hand, when GSH levels are enhanced by administration of GSH or its precursors, the depletion of GSH levels by EtOH are prevented [19, 20] and toxicity is diminished [21-26].

GSH depletion is also an important factor in the aging process. Previous results from this laboratory and others have demonstrated that a GSH deficiency is a common phenomenon of senescent organisms, including humans [27-31]. While the mechanisms responsible for this aging impairment are unknown, several studies indicate that a decrease in turnover of GSH and a loss of biosynthetic capacity may be involved [32-34]. Based on these results and on the numerous functions of GSH in cellular homeostasis and defense [35], a loss of GSH may represent a critical factor in the aging process [36].

The effect of aging on GSH status during EtOH intoxication has received little attention. In one study, old female Fischer 344 rats administered a dose of 4 g/kg EtOH exhibited a depletion of hepatic GSH comparable to that of mature and young rats [37]. However, in this study, only one dose of EtOH was examined and the confounding factor of fasting was not taken into account in the experimental design. Indeed, fasting is known to impact hepatic GSH levels and hepatotoxicity [38, 39] and we have observed that fasting-induced GSH depletion was greater in old than in younger animals [34]. In another study, effects of age were examined in younger age groups, so that results reflected growth and maturational changes rather than the aging process per se [40].

The aim of the present study is to systematically examine the effects of aging on EtOH-induced GSH depletion and recovery in the mouse. To test this, GSH concentrations in various tissues were determined in young, mature and old mice throughout a 24-hr time course after acute EtOH treatment, and after increasing doses of EtOH. Special attention was placed on comparison of EtOH-treated mice with time-matched controls, to account for the decreases in GSH resulting from food deprivation [34]. Also examined were the effects of EtOH on the tissue concentrations of GSH related metabolites, cyst(e)ine and glutathione disulfide (GSSG).

Materials And Methods

Experimental Animals

Male C57Bl/6NNIA mice of ages 6 months (young), 12 months (mature adults), and 24 months (old) were obtained from colonies administered by the National Institute on Aging, as described previously [34]. Prior to experimentation, which began at 8 a.m., mice had free access to food (NIH-07) and water. After dosing, food but not water was withheld until termination of the experiment. Mice from each of the age groups were utilized within an experimental period.

Experimental Protocols

For dose-response studies, mice were weighed and injected i.p. with 2, 3, 4, or 5 g/kg EtOH as a 20% (w/v) solution in 0.9% NaCl warmed to 37°C. Control mice received i.p. injections of 20 ml/kg 0.9% NaCl, corresponding to the volume of the 4 g/kg EtOH dose. All dose-response data were obtained from mice sacrificed at 6 hr. after injection. Time course data were obtained from animals sacrificed at 0, 2, 6 and 24 hr. after administration of EtOH. Animals were anesthetized with diethyl ether and exsanguinated by cardiac puncture. Whole blood was collected into syringes containing 100 æl of 0.05 M disodium EDTA (Sigma, St. Louis, MO). Liver, kidneys and lung were excised quickly, trimmed, rinsed in ice-cold 0.9% (w/v) saline to remove blood, blotted dry and weighed.

Tissue Processing

Whole blood was processed by the addition of four volumes of ice-cold 5% (w/v) metaphosphoric acid (MPA) (Mallinckrodt, Paris, KY). Liver, kidney and lung samples were homogenized (10%, w/v) in 5% MPA using an all-glass Ten-Broeck homogenizer, and centrifuged at 14,000 × g for 3 min. The protein-free supernatants of blood and tissues were stored at -70°C until assayed for glutathione and cyst(e)ine. Additional tissue samples were homogenized in ice-cold 1.5% (w/v) KCl for immediate analysis of thiobarbituric acid-reactive substances (TBARS).

Analytical Methods

Total glutathione (GSH and glutathione disulfide, GSSG) was assayed enzymatically as previously described [41]. Analysis of selected samples by HPLC with electrochemical detection [42] demonstrated that total GSH was comprised of approximately 95% GSH and GSSG levels were low and unchanged as a result of EtOH administration. Cyst(e)ine (cysteine + cystine) was determined as previously described [43]. Thiobarbituric acid reactive substances were determined as described previously and expressed as pmol/mg of protein [44].

Statistical Analysis

Data are expressed as mean ± standard error of the mean (SEM). Differences between groups were considered significant at P<0.05. Two-way analysis of variance (ANOVA) was employed to determine the main effects of age and time, or age and dose. Significant interactions of age by time or dose were followed up with one-way ANOVA and Scheffe’s post-hoc test to identify specific group effects. Analysis of covariance (ANCOVA) was also used to identify age effects that exist in time or dose trends. Linear and nonlinear regression were utilized to model selected dose-response data. All statistical analyses were performed using SAS software.

Results

Time Course of EtOH Effects

The time course of EtOH-induced depletion and recovery of hepatic GSH in mice of different ages is shown in Table 1. By 6 hr after administration of 5 g/kg EtOH, GSH levels were depleted 52, 57 and 63%, in mice of ages 6, 12 and 24 mo. respectively (P<0.001). While the extent of the drop was similar among all age groups, mice of different ages demonstrated divergent recovery patterns by 24 hr. Only mature 12 mo. old mice displayed a significant increase in GSH from 6 hr, reaching a level comparable to their initial GSH concentration by 24 hr. GSH levels in young and old mice remained low, displaying no apparent recovery. Thus, at 24 hr, hepatic GSH levels in mature ethanol-treated mice were significantly higher than those of the young or old mice (P<0.05).

Table 1.

Effect of acute ethanol administration on hepatic glutathione levels

Glutathione (μmol/g tissue)
Age: 6 mo 12 mo 24 mo
Time (hr) Control Ethanol Control Ethanol Control Ethanol
0 8.84 ± 0.49 8.62± 0.24 8.54 ± 0.51
2 8.80 ± 1.08 5.41 ± 0.71* 8.71 ± 0.21 6.46 ± 0.57* 8.46 ± 0.96 6.91 ± 0.65
6 8.08 ± 0.34 4.19 ± 0.50* 7.46 ± 0.41 4.22 ± 0.28* 6.01 ± 0.62 3.82 ± 0.36*
24 7.92 ± 0.33 5.55 ± 0.70*, 5.62 ± 0.54 8.88 ± 0.36* 4.29 ± 0.51 5.53 ± 0.96

Mice were administered 5 g/kg EtOH; values are mean ± SEM, n=4

*

significantly different from controls, P<0.05.

significantly different from ethanol-treated 12 mo group, P<0.05.

significantly different from baseline (0 hr) control, P<0.05.

In these experiments, absolute GSH values represent the effects of both EtOH and food deprivation, as food was withheld throughout the 24 hours to prevent confounding effects of differential food consumption. As we observed previously, changes in GSH levels due to fasting alone were observed for all age groups (Table 1). By 24 hr in control mice, GSH levels decreased 10%, 35% and 50% in 6, 12 and 24 mo. old mice, respectively (P<0.05). Decreases were observed after only 6 hr in both mature and old age groups. Therefore, in order to identify effects due specifically to EtOH, GSH concentrations in EtOH-treated mice were examined relative to saline-injected, agematched controls at each time point (Figure 1). Mice of all ages exhibited a similar decrease in GSH due to EtOH exposure with a maximum decrease of 62, 52 and 70% at 6 hr in young, mature and old mice, respectively. This decrease in GSH was maintained though 24 hr in young mice where levels were 30% lower than fasted controls (P<0.05). However, in mature mice GSH levels rebounded to 158% of fasted controls by 24 hr (P<0.05), while in old mice levels were not significantly different from those in fasted controls after 24 hrs.

Fig. 1.

Fig. 1

Time course of hepatic glutathione depletion and recovery after ethanol administration. Mice were sacrificed 2, 6 and 24 hr after i.p. administration of 5 g/kg EtOH. Total glutathione (GSH + GSSG) was expressed as μeq. GSH/g tissue. Results are shown as mean ±SE of 4-10 mice per age group. * significantly different from 0 time point, P<0.05; † significantly different from 6 hr time point, P<0.05; ‡ significantly different from 12 mo age group, P<0.05.

The time course of EtOH-induced GSH depletion and recovery in the kidney is presented in Table 2. By 6 hr after administration of 5 g/kg EtOH, GSH levels were depleted by 28, 25 and 19% in mice of ages 6, 12 and 24 mo., respectively (P<0.05). A complete recovery of GSH levels occurred in all mice by 24 hr with the greatest increase being observed in mature animals. Thus, in a manner similar to that of liver, renal GSH levels were significantly greater in mature mice than in either young or old animals 24 hr after EtOH administration (P<0.05).

Table 2.

Effect of acute ethanol administration on renal glutathione levels

Glutathione (μmol/g tissue)
Age: 6 mo 12 mo 24 mo
Time (hr) Control Ethanol Control Ethanol Control Ethanol
0 3.49 ± 0.19 3.14 ± 0.24 2.44 ± 0.21
2 3.66 ± 0.22 2.90 ± 0.25 3.29 ± 0.19 2.60 ± 0.25 2.38 ± 0.20 2.47 ± 0.15
6 3.27 ± 0.18 2.51 ± 0.17 3.10 ± 0.16 2.35 ± 0.16 2.57 ± 0.19 1.98 ± 0.14
24 3.65 ± 0.20 3.31 ± 0.27 2.88 ± 0.20 4.18 ± 0.22* 2.35 ± 0.23 2.75 ± 0.22

Mice were administered 5 g/kg EtOH; values are mean ± SEM, n=4.

*

significantly different from controls, P<0.05.

significantly different from baseline (0 hr) controls, P<0.05.

significantly different from 6 mo control, P<0.05.

In contrast to liver, no consistent changes in renal glutathione levels were observed due to fasting alone (Table 2). Thus, when the effects of EtOH on renal GSH were also analyzed relative to fasted controls, similar results were observed (Figure 2). At 6 hr, GSH levels were significantly lower in EtOH-treated mice than fasted controls in all age groups (P<0.05). Similar to liver, an overshoot of GSH was observed in mature animals at 24 hr compared to fasted mice (P<0.05), whereas no differences were observed in either young or mature animals due to EtOH.

Fig. 2.

Fig. 2

Time course of renal glutathione depletion and recovery after ethanol administration. Mice were sacrificed 2, 6 and 24 hr after i.p. administration of 5 g/kg EtOH. Total glutathione (GSH + GSSG) was expressed as μeq. GSH/g tissue. Results are shown as mean ± SE of 4-10 mice per age group. * significantly different from 0 time point, P<0.05; † significantly different from 6 hr time point, P<0.05; ‡ significantly different from 12 mo age group, P<0.05.

Hepatic cyst(e)ine levels did not differ according to time or age in control or EtOH-treated mice (data not shown). However, aging, fasting and EtOH specific changes in renal cyst(e)ine concentrations were observed (Table 3). Initial Cys levels in mature and old mice were 22 and 21% lower, respectively, than in young mice (P<0.05). Mice of all ages displayed different renal Cys profiles in response to fasting. In young mice, Cys levels were unchanged through 6 hr and subsequently decreased to 64% of initial levels after 24 hr (P<0.05). In mature mice, Cys levels increased 17% after 6 hr (P<0.05) and returned to baseline values by 24 hr. Old mice displayed declining Cys concentration throughout the 24 hr time period, ending with a level 70% of that of initial levels (P<0.05).

Table 3.

Effect of acute ethanol administration on renal cyst(e)ine levels

Cyst(e)ine (μeq. Cys/g tissue)
Age: 6 mo 12 mo 24 mo
Time (hr) Control Ethanol Control Ethanol Control Ethanol
0 1.23 ± 0.059 0.964 ± 0.077 0.845 ± 0.071
2 1.18 ± 0.075 0.796 ± 0.080* 0.840 ± 0.096 0.916 ± 0.062 0.890 ± 0.090 0.621 ± 0.084*,§
6 1.32 ± 0.093 0.768 ± 0.073* 1.13 ± 0.087* 0.679 ± 0.059 0.831 ± 0.095 0.619 ± 0.062*
24 0.783 ± 0.047* 1.07 ± 0.058 0.835 ± 0.093 1.13 ± 0.062 0.623 ± 0.104*, 0.523 ± 0.032*,,§

Mice were administered 5 g/kg EtOH; values are mean ± SEM, n=4

*

significantly different from baseline (0 hr) control, P<0.05.

significantly different from 6 mo., P<0.05.

significantly different from 6 hr., P<0.05.

§

significantly different from 12 mo., P<0.05.

A depletion in renal Cys levels after EtOH administration was observed in only young animals after 2 and 6 hr (P<0.05) (Table 3). By 24 hr, increased Cys levels were evident in both young and mature animals compared to 6 hr values (P<0.05). In old mice, renal cyst(e)ine levels decreased throughout the entire time course to levels 42% lower than initial values and lower than that of the other two age groups (P<0.05). When renal cyst(e)ine levels were examined relative to fasted, saline-injected controls (Figure 3), similar patterns were observed. In the young and mature mice, cyst(e)ine levels were 40% lower than controls at 6 hr and 40% greater than control at 24 hr (P<0.05). In old mice, renal cyst(e)ine levels were 20-30% lower than fasted controls at all time points (P<0.05).

Fig. 3.

Fig. 3

Time course of renal cyst(e)ine depletion and recovery after ethanol administration. Mice were sacrificed 2, 6 and 24 hr after i.p. administration of 5 g/kg EtOH. Cyst(e)ine (cysteine + cystine) was expressed as μeq. Cys/g tissue. Results are shown as mean ± SE of 4-10 mice per age group. * significantly different from 0 time point, P<0.05; † significantly different from 6 hr time point, P<0.05; ‡ significantly different from 12 mo age group, P<0.05; § significantly different from 6 mo. age group, P<0.05.

Fasting and EtOH administration had no effect on whole blood GSH levels (data not shown). While an over all significant effect of time was observed by ANOVA (P<0.03), no differences between specific time points could be discerned by post hoc analyses.

Effects of EtOH administration on liver levels of TBARS are presented in Table 4. In control rats, levels of TBARS were increased with advancing age across all age groups (P<0.05). For both 6 and 12 mo old rats, an increase in TBARS was observed 24 hr after EtOH administration (P<0.05). In old rats, an increase in TBARS was observed 6 and 24 hr after EtOH administration (P<0.05).

Table 4.

Time Course of Liver TBARS after Ethanol Administration

TBARS (pmol/mg protein)
Time (hr) Age: 6 mo 12 mo 24 mo
0 421 ± 36.1** 604 ± 71.1§ 763 ± 74.1§,**
2 440 ± 40.8 589 ± 64.2 819 ± 64.0
6 462 ± 39.4 671 ± 60.2 903 ± 86.6*
24 651 ± 74.0*,, 784 ± 50.6*,, 965 ± 90.9*,

Mice were administered 5 g/kg EtOH; values are mean ± SEM, n=4-10.

*

significantly different from baseline (0 hr) control, P<0.05.

significantly different from 2 hr., P<0.05.

significantly different from 6 hr., P<0.05.

§

significantly different from 6 mo., P<0.05.

**

significantly different from 12 mo., P<0.05.

Dose-Response of GSH to EtOH

Liver and kidney GSH concentrations 6 hr after administration of increasing doses of EtOH are presented in Figure 4. The 6 hr time point was selected as the time of maximal depletion of GSH after EtOH administration. In the liver, EtOH administration resulted in an overall depletion of GSH in all 3 age groups. For the young and mature mice, significant decreases were observed for EtOH doses of 2, 3, 4, and 5 g/kg, while in old mice, significant decreases occurred only at the 3 and 5 g/kg doses (P<0.05). GSH levels in most groups tended to decrease with increasing dose of EtOH through 3 g/kg with the lowest GSH level observed for the old 24 mo mice administered 3 g/kg EtOH. At doses above 3 g/kg, GSH concentrations did not further diminish, and mice of all three ages displayed comparable levels of GSH at 4 and 5 g/kg EtOH. While age was a significant covariate in the depletion of GSH by EtOH (P<0.02), specific differences between age groups were only observed at the 3 g/kg EtOH dose where lower levels in both young and old mice were observed compared to mature mice (P<0.05).

Fig. 4.

Fig. 4

Response of hepatic and renal glutathione to increasing doses of ethanol. Mice were sacrificed 6 hr after administration of ethanol i.p. on a body weight basis. Total GSH (GSH + GSSG) was expressed as μmol GSH/g liver or kidney. Results are shown as mean ± SEM of 4-6 mice per age group. * significantly different from saline-injected controls, P<0.05; † significantly different from 12 mo. age group, P<0.05; ‡ significantly different from 6 mo age group, P<0.05.

In the kidney, both age and EtOH dose-dependent decreases were observed for GSH levels 6 hr after administration of EtOH. Levels of GSH tended to decrease with increasing dose of EtOH (P<0.0001), particularly in the higher dose groups of 4 and 5 g/kg where mean values were significantly lower than saline-injected controls (P<0.05). The kidney was less sensitive to GSH depletion by EtOH than the liver, as GSH values were lowered to only 75% of control values at the highest dose of EtOH administered. Age was also in important factor with old mice having significantly lower levels than either of the 2 younger age groups at each dose of EtOH (P<0.05). Age was also a highly significant covariate in determining renal GSH levels by ANCOVA (P<0.0001).

The response of cyst(e)ine levels in liver to increasing doses of EtOH is presented in Table 5. Significant decreases in hepatic cyst(e)ine levels were observed in all mice 6 hr after administration of 2 g/kg EtOH (P<0.05). While mean levels were 18 to 42% lower at higher doses, differences did not reach the level of significance. An overall effect of age was also apparent with lower levels being observed in younger mice (P<0.02).

Table 5.

Response of cyst(e)ine concentrations in Liver and Kidney to increasing doses of ethanol

Cyst(e)ine (μeq. Cys/g tissue)
Dose (g/kg) Age: 6 mo 12 mo 24 mo
Liver
0 0.25 ± 0.04 0.38 ± 0.04 0.29± 0.04
2 0.13 ± 0.05 0.16 ± 0.05 0.17 ± 0.05*
3 0.17 ± 0.04 0.22 ± 0.05 0.24 ± 0.05
4 0.16 ± 0.05 0.23 ± 0.03 0.23 ± 0.04
5 0.18 ± 0.04 0.24 ± 0.04 0.23 ± 0.04
Kidney
0 1.32 ± 0.08 1.13 ± 0.07 0.84 ± 0.07*
2 1.47 ± 0.10 0.86 ± 0.10 0.53 ± 0.10
3 1.15 ± 0.08 1.07 ± 0.08 0.79 ± 11
4 0.93 ± 0.09 0.70 ± 0.07 0.63 ± 0.07
5 0.77 ± 0.07 0.68 ± 0.06 0.62 ± 0.07

Mice were administered EtOH at the indicated doses and sacrificed after 6 hr.; values are mean ± SEM, n=4-10.

*

Significantly different from young mice, P<0.05

Significantly different from saline-injected control, P<0.05.

Renal cyst(e)ine concentrations were reduced by increasing doses of EtOH in young and mature mice (Table 5) (P<0.0001). Significant decreases from controls were observed at 5 g/kg in young mice, and at both 4 and 5 g/kg in the mature animals (P<0.05). No significant differences were observed in old mice at any dose of EtOH. However, initial cyst(e)ine levels in old mice were significantly lower than in young or mature animals (P<0.05).

GSH levels in blood and lung tissue in animals of different ages 6 hr after EtOH administration are reported in Table 6. In lung, aging resulted in a significantly lower baseline concentration of GSH (P<0.03). There were no significant dose-response effects attributable to EtOH. In blood, GSH concentrations were dependent upon age with each age group differing significantly from each other (P<0.05). Again, there were no significant changes in GSH concentration due to EtOH.

Table 6.

Response of glutathione concentrations in lung and blood to increasing doses of ethanol

GSH (μmol/g tissue)
Dose (g/kg) Age: 6 mo 12 mo 24 mo
Lung
0 2.34 ± 0.16 2.44 ± 0.09 1.79 ± 0.16*
3 2.43 ± 0.07 1.91 ± 0.05 1.65 ± 0.17
4 2.59 ± 0.11 1.94 ± 0.10 1.89 ± 0.07
5 2.43 ± 0.11 1.89 ± 0.09 1.69 ± 0.06
Whole Blood
0 1.29 ± 0.09 1.11 ± 0.07 0.79 ± 0.09
3 1.27 ± 0.10 1.18 ± 0.10 1.01 ± 0.16
4 1.24 ± 0.09 1.20 ± 0.07 0.84 ± 0.08
5 1.18 ± 0.07 1.08 ± 0.08 0.89 ± 0.09

Mice were administered 5 g/kg EtOH; values are mean ± SEM, n=4-10.

*

Significantly different from mature mice, P<0.05.

Significantly different from 6 mo age group, P<0.05.

Discussion

This is the first systematic examination of the effects of EtOH on GSH status in mice throughout their life span, with special emphasis on the aging period. The approach included time course studies in order to examine both EtOH-induced GSH depletion and recovery phases. Depletion likely results from the intracellular utilization of GSH as a result of EtOH exposure, as well as, in the liver, efflux of GSH from hepatocytes into the blood. The recovery period likely results from enhanced hepatic GSH biosynthesis, but is also affected by continued efflux from the liver. An important design characteristic of our studies was the withholding of food throughout the 24 hr experimental period. This constraint was applied in order to avoid differential amounts of food consumed by animals of different ages in different states of intoxication, a possibility not commonly accounted for in previous studies. Hepatic GSH levels are greatly affected by diet and fasting alone severely depletes hepatic GSH stores in as little as 6 hrs [34]. Fasting-induced GSH depletion in the liver is thought to result from a reduction in its de novo biosynthesis due to decreased levels of circulating Cys, its rate-limiting precursor. Consequently, changes in GSH levels after administration of intoxicating doses of EtOH will likely represent the combined effects of both EtOH and food deprivation.

Administration of 5 g/kg EtOH resulted in a significant 37-48% depletion of hepatic GSH in mice of all ages after 6 hr, consistent with previous studies in young animals [14]. Further, a significantly lower absolute concentration of GSH was obtained in old mice after administration of 3 g/kg EtOH compared to younger animals. In animals of all ages, the depletion was dose-dependent only up to 3 g/kg, with no further decline observed at higher doses perhaps as a result of hepatotoxicity since glutathione Stransferases (GSTs) are impaired at these higher doses [45]. Previous reports concerning age effects on the extent of EtOH-induced GSH depletion have been conflicting. The degree of depletion of hepatic GSH by p.o. administration of 5 g/kg EtOH was lower in mature compared to young Wistar rats [46], however, this difference could have resulted from an overnight fasting. Rikans and Snowden [37] reported equivalent depletion of hepatic GSH after 4 g/kg EtOH (i.p.) in young, mature and old female F344 rats. The present results are consistent with these reports as mature animals were depleted less extensively than young mice at selected doses (3 g/kg), while at higher doses (5 g/kg) the degree of depletion was similar across age groups. Chronic EtOH administration also depleted hepatic GSH levels to a greater extent in old (18 mo) rats compared to young (3 mo) animals [47].

The mechanism of EtOH-induced depletion of GSH may involve the direct conjugation of GSH with acetaldehyde (AcH), the reactive intermediate of EtOH oxidation [48, 49]. While GSH-AcH conjugates have not always been observed in vitro [50, 51], high concentrations of GSH in hepatocytes makes this reaction a likely candidate to explain GSH protection against EtOH toxicity. Adduct formation of AcH with Cys or cysteinylglycine rather than GSH has also been suggested as a mechanism of EtOH-induced GSH depletion [50], however, the steady state levels of these thiols are much lower that for GSH in the liver. However, in the kidney where steady state levels of Cys are significantly higher, conjugation of Cys conjugation may play a more important role.

Other mechanisms for EtOH-induced hepatic GSH depletion may involve increased efflux of GSH from the liver as observed previously [52, 53] or enhanced utilization of GSH for the detoxification of free radicals and oxidants produced as a result of EtOH exposure [17, 54-56]. The role of GSH in protection against EtOH-induced oxidative stress is well-established [56-58] and human studies have suggested that alterations in GSH metabolism in erythrocytes of alcoholics are principally due to this protective function [59]. However, while the present findings suggest that lipid peroxidation was enhanced after EtOH administration, as assessed by liver TBARS, this increase was not apparent until after GSH levels had been depleted.

The most striking aging differences were observed in the recovery phase in the liver as both young and old mice failed to replenish GSH levels after EtOH treatment combined with food deprivation. These finding suggest that the biosynthetic capacity for replenishing GSH stores may be altered during aging, affecting the recovery of GSH after depletion by EtOH. A reduction in GSH biosynthetic capacity during aging has been implicated in previous studies [33]. The decreased levels of Cys observed in the kidney after 24 hr in old mice may be indicative of a reduction in hepatic GSH biosynthesis and efflux in these animals. Renal Cys levels have been utilized as an indirect indicator of efflux since the majority of GSH transported from the sinusoidal membrane of the liver into the plasma ends up being degraded in the kidney by the enzyme γ-glutamyl transpeptidase resulting in the release of Cys [60]. Administration of radiolabelled GSH monoethylester resulted in quantitative increases in renal Cys concentration and in the labeling of the renal Cys pool to a similar specific activity as that of administered GSH [61]. Additionally, others have reported significant increases in renal Cys after i.p. or i.v. administration of GSH [62, 63]. The rebound of renal Cys levels in young and mature mice after 24 hr may indicate that hepatic efflux has returned to baseline levels, while the reduction of Cys in old mice may reflect a lower rate of GSH synthesis and turnover, possibly as a result of fasting as previously observed in old animals [64].

Our observation that the recovery of hepatic GSH levels after EtOH administration in young mice is less than complete is consistent with a pervious finding in mice [22] but contrasts with other studies in young rats, in which hepatic GSH levels were fully recovered by 18 hr [14]. While this discrepancy may represent differential speciesspecific responses to EtOH, It could also be the result of differences in food consumption or availability between studies as hepatic GSH levels are dependent upon precursor amino acids for GSH synthesis. Additionally, an overnight fasting period prior to ethanol administration was included in many of these studies, which likely altered GSH homeostasis [65, 66]. Since, in the present study, the loss of GSH due to starvation was minimal in young mice, the inability to recover from EtOH-induced GSH depletion was due to specific long-lasting effects of EtOH. One possible explanation for this age-related difference may be that young mice have an increased requirement for Cys, the rate-limiting precursor of GSH. Protein synthesis is known to compete with GSH synthesis for limited concentrations of Cys [67]. Metallothionein, a protein in which Cys comprises 30% of the amino acid residues, is induced ten-fold at 24 hr after acute EtOH administration in young rats and mice [68-70]. Additionally, ethanol induces the rapid synthesis of stress proteins in young animals [71, 72] while production of stress proteins is diminished in aging animals [73-75]. Thus, it is possible that in young animals, but less so in mature and old, an increase in protein synthesis occurs after exposure to high doses of EtOH, at the expense of GSH synthesis. This is consistent with other reports in which incorporation of radiolabelled amino acids into GSH was diminished after EtOH administration in young animals [76, 77].

Alterations in GSH content and efflux as a result of EtOH exposure may, in part, explain the increased susceptibility of old organisms to EtOH. The lower absolute levels of GSH observed after EtOH administration in old mice compared to younger animals may result in a greater extent of EtOH-induced liver damage, as reactive oxygen species or intermediates are detoxified to a lesser extent by GSH. During GSH depletion and recovery periods, vulnerability to the adverse effects of other compounds is increased, as observed with acetaminophen, aflatoxin B1, and cocaine after EtOH exposure [78-80]. Additionally, the decreased rate of GSH efflux from the liver suggested in this study may enhance EtOH-mediated damage to other organ systems. Aging-related decreases in brain GSH content, as have been documented earlier [78], may contribute to the aging-related enhancement of neurological and psychomotor sensitivity to ethanol [7, 8, 81]. Indeed, GSH and GSSG have been found to interact with the N-methyl-D-aspartate (NMDA) receptor and antagonize EtOH-induced hypnosis [82, 83]. Thus, GSH depletion could be an important factor in the neurological toxicity of EtOH displayed by the elderly.

In summary, animal age was found to significantly impact upon GSH depletion and recovery at selected times after EtOH administration. These age effects were most evident in the recovery of GSH by 24 hr after initiation of EtOH treatment and food deprivation. Overall, a more severe depletion and impaired recovery of hepatic GSH may represent a possible biological basis for greater susceptibility of old organisms to the adverse effects of EtOH.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • [1].Moos RH, Brennan PL, Schutte KK, Moos BS. High-risk alcohol consumption and late-life alcohol use problems. Am J Public Health. 2004;94:1985–91. doi: 10.2105/ajph.94.11.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [2].Adams WL, Yuan Z, Barboriak JJ, Rimm AA. Alcohol-related hospitalizations of elderly people. Prevalence and geographic variation in the United States. Jama. 1993;270:1222–5. [PubMed] [Google Scholar]
  • [3].Rigler SK. Alcoholism in the elderly. Am Fam Physician. 2000;61 passim.
  • [4].Martin J, Streissguth A. Treatment of psychopathology in the aging. Springer Pub. Co.; New York: 1982. [Google Scholar]
  • [5].United States. Bureau of the Census . Projections of the population of the United States, by age, sex, and race: 1988-2080. U.S. Dept. of Commerce For sale by the Supt. of Docs.; Washington, D.C.: 1989. [Google Scholar]
  • [6].Mendenhall CL, Gartside PS, Roselle GA, Grossman CJ, Weesner RE, Chedid A. Longevity among ethnic groups in alcoholic liver disease. Alcohol Alcohol. 1989;24:11–9. [PubMed] [Google Scholar]
  • [7].Ryan C. Alcoholism and premature aging: a neuropsychological perspective. Alcohol Clin Exp Res. 1982;6:22–30. doi: 10.1111/j.1530-0277.1982.tb05378.x. [DOI] [PubMed] [Google Scholar]
  • [8].Oscar-Berman M. Learning and memory deficits in detoxified alcoholics. NIDA Res Monogr. 1990;101:136–55. [PubMed] [Google Scholar]
  • [9].Hahn HK, Burch RE. Impaired ethanol metabolism with advancing age. Alcohol Clin Exp Res. 1983;7:299–301. doi: 10.1111/j.1530-0277.1983.tb05464.x. [DOI] [PubMed] [Google Scholar]
  • [10].Lucey MR, Hill EM, Young JP, Demo-Dananberg L, Beresford TP. The influences of age and gender on blood ethanol concentrations in healthy humans. J Stud Alcohol. 1999;60:103–10. doi: 10.15288/jsa.1999.60.103. [DOI] [PubMed] [Google Scholar]
  • [11].Seitz HK, Meydani M, Ferschke I, Simanowski UA, Boesche J, Bogusz M, et al. Effect of aging on in vivo and in vitro ethanol metabolism and its toxicity in F344 rats. Gastroenterology. 1989;97:446–56. doi: 10.1016/0016-5085(89)90082-6. [DOI] [PubMed] [Google Scholar]
  • [12].Vestal RE, McGuire EA, Tobin JD, Andres R, Norris AH, Mezey E. Aging and ethanol metabolism. Clin Pharmacol Ther. 1977;21:343–54. doi: 10.1002/cpt1977213343. [DOI] [PubMed] [Google Scholar]
  • [13].York JL. Increased responsiveness to ethanol with advancing age in rats. Pharmacol Biochem Behav. 1983;19:687–91. doi: 10.1016/0091-3057(83)90346-5. [DOI] [PubMed] [Google Scholar]
  • [14].Videla L, Guerri C. Glutathione and alcohol. CRC Press; Boca Raton: 1990. [Google Scholar]
  • [15].Choi DW, Kim SY, Kim SK, Kim YC. Factors involved in hepatic glutathione depletion induced by acute ethanol administration. J Toxicol Environ Health A. 2000;60:459–69. doi: 10.1080/00984100050079520. [DOI] [PubMed] [Google Scholar]
  • [16].Guerri C, Grisolia S. Changes in glutathione in acute and chronic alcohol intoxication. Pharmacol Biochem Behav. 1980;13(Suppl 1):53–61. doi: 10.1016/s0091-3057(80)80009-8. [DOI] [PubMed] [Google Scholar]
  • [17].Calabrese V, Testa G, Ravagna A, Bates TE, Stella AM. HSP70 induction in the brain following ethanol administration in the rat: regulation by glutathione redox state. Biochem Biophys Res Commun. 2000;269:397–400. doi: 10.1006/bbrc.2000.2311. [DOI] [PubMed] [Google Scholar]
  • [18].Strubelt O, Younes M, Pentz R. Enhancement by glutathione depletion of ethanol-induced acute hepatotoxicity in vitro and in vivo. Toxicology. 1987;45:213–23. doi: 10.1016/0300-483x(87)90107-7. [DOI] [PubMed] [Google Scholar]
  • [19].Vina J, Estrela JM, Guerri C, Romero FJ. Effect of ethanol on glutathione concentration in isolated hepatocytes. Biochem J. 1980;188:549–52. doi: 10.1042/bj1880549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Ponsoda X, Jover R, Gomez-Lechon MJ, Fabra R, Trullenque R, Castell JV. Intracellular glutathione in human hepatocytes incubated with S-adenosyl-Lmethionine and GSH-depleting drugs. Toxicology. 1991;70:293–302. doi: 10.1016/0300-483x(91)90004-k. [DOI] [PubMed] [Google Scholar]
  • [21].Sprince H, Parker CM, Smith GG, Gonzales LJ. Protection against acetaldehyde toxicity in the rat by L-cysteine, thiamin and L-2-methylthiazolidine-4-carboxylic acid. Agents Actions. 1974;4:125–30. doi: 10.1007/BF01966822. [DOI] [PubMed] [Google Scholar]
  • [22].Macdonald CM, Dow J, Moore MR. A possible protective role for sulphydryl compounds in acute alcoholic liver injury. Biochem Pharmacol. 1977;26:1529–31. doi: 10.1016/0006-2952(77)90428-2. [DOI] [PubMed] [Google Scholar]
  • [23].Ryle PR, Chakraborty J, Thomson AD. Effects of cysteine and antioxidants on the hepatic redox-state, acetaldehyde and triglyceride levels after acute ethanol dosing. Alcohol Alcohol Suppl. 1987;1:289–93. [PubMed] [Google Scholar]
  • [24].Loguercio C, Taranto D, Beneduce F, del Vecchio Blanco C, de Vincentiis A, Nardi G, et al. Glutathione prevents ethanol induced gastric mucosal damage and depletion of sulfhydryl compounds in humans. Gut. 1993;34:161–5. doi: 10.1136/gut.34.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Bresci G, Piccinocchi M, Banti S. [The use of reduced glutathione in alcoholic hepatopathy] Minerva Med. 1991;82:753–5. [PubMed] [Google Scholar]
  • [26].Pistelli A, Di Simplicio P, Di Bello MG, Raspanti S, Gambassi F, Botti P, et al. [Contribution of glutathione to detoxification in alcoholism. Biochemical-clinical studies] Clin Ter. 1992;140:461–71. [PubMed] [Google Scholar]
  • [27].Hazelton GA, Lang CA. Glutathione contents of tissues in the aging mouse. Biochem J. 1980;188:25–30. doi: 10.1042/bj1880025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Hazelton GA, Lang CA. Glutathione levels during the mosquito life span with emphasis on senescence. Proc Soc Exp Biol Med. 1984;176:249–56. doi: 10.3181/00379727-176-41867. [DOI] [PubMed] [Google Scholar]
  • [29].Chen TS, Richie JP, Jr., Lang CA. The effect of aging on glutathione and cysteine levels in different regions of the mouse brain. Proc Soc Exp Biol Med. 1989;190:399–402. doi: 10.3181/00379727-190-42879. [DOI] [PubMed] [Google Scholar]
  • [30].Rathbun WB, Murray DL. Age-related cysteine uptake as rate-limiting in glutathione synthesis and glutathione half-life in the cultured human lens. Exp Eye Res. 1991;53:205–12. doi: 10.1016/0014-4835(91)90075-p. [DOI] [PubMed] [Google Scholar]
  • [31].Lang CA, Naryshkin S, Schneider DL, Mills BJ, Lindeman RD. Low blood glutathione levels in healthy aging adults. J Lab Clin Med. 1992;120:720–5. [PubMed] [Google Scholar]
  • [32].Hazelton GA, Lang CA. Glutathione peroxidase and reductase activities in the aging mouse. Mech Ageing Dev. 1985;29:71–81. doi: 10.1016/0047-6374(85)90048-x. [DOI] [PubMed] [Google Scholar]
  • [33].Richie JP, Jr., Lang CA. A decrease in cysteine levels causes the glutathione deficiency of aging in the mosquito. Proc Soc Exp Biol Med. 1988;187:235–40. doi: 10.3181/00379727-187-42660. [DOI] [PubMed] [Google Scholar]
  • [34].Vogt BL, Richie JP., Jr. Fasting-induced depletion of glutathione in the aging mouse. Biochem Pharmacol. 1993;46:257–63. doi: 10.1016/0006-2952(93)90412-p. [DOI] [PubMed] [Google Scholar]
  • [35].Vina J, Guillermo T, Vina J. CRC Handbook of free radicals and antioxidants in biomedicine. CRC Press; Boca Raton, Fla.: 1989. [Google Scholar]
  • [36].Richie JP., Jr. The role of glutathione in aging and cancer. Exp Gerontol. 1992;27:615–26. doi: 10.1016/0531-5565(92)90015-r. [DOI] [PubMed] [Google Scholar]
  • [37].Rikans LE, Snowden CD. Effects of acute ethanol administration on female rat liver as a function of aging. Life Sci. 1989;45:1373–9. doi: 10.1016/0024-3205(89)90024-6. [DOI] [PubMed] [Google Scholar]
  • [38].Maruyama E, Kojima K, Higashi T, Sakamoto Y. Effect of diet on liver glutathione and glutathione reductase. J Biochem (Tokyo) 1968;63:398–9. [PubMed] [Google Scholar]
  • [39].Pessayre D, Dolder A, Artigou JY, Wandscheer JC, Descatoire V, Degott C, et al. Effect of fasting on metabolite-mediated hepatotoxicity in the rat. Gastroenterology. 1979;77:264–71. [PubMed] [Google Scholar]
  • [40].Kim YC, Kim SY, Sohn YR. Effect of age increase on metabolism and toxicity of ethanol in female rats. Life Sci. 2003;74:509–19. doi: 10.1016/j.lfs.2003.07.009. [DOI] [PubMed] [Google Scholar]
  • [41].Richie JP, Jr., Skowronski L, Abraham P, Leutzinger Y. Blood glutathione concentrations in a large-scale human study. Clin Chem. 1996;42:64–70. [PubMed] [Google Scholar]
  • [42].Kleinman WA, Richie JP., Jr. Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol. 2000;60:19–29. doi: 10.1016/s0006-2952(00)00293-8. [DOI] [PubMed] [Google Scholar]
  • [43].Gaitonde MK. A spectrophotometric method for the direct determination of cysteine in the presence of other naturally occurring amino acids. Biochem J. 1967;104:627–33. doi: 10.1042/bj1040627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Gutteridge JM, Galliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem Sci. 1990;15:129–35. doi: 10.1016/0968-0004(90)90206-q. [DOI] [PubMed] [Google Scholar]
  • [45].Yang CM, Carlson GP. Effects of ethanol on glutathione conjugation in rat liver and lung. Biochem Pharmacol. 1991;41:923–9. doi: 10.1016/0006-2952(91)90197-d. [DOI] [PubMed] [Google Scholar]
  • [46].Videla LA, Fernandez V, Valenzuela A. Age-dependent changes in rat liver lipid peroxidation and glutathione content induced by acute ethanol ingestion. Cell Biochem Funct. 1987;5:273–80. doi: 10.1002/cbf.290050406. [DOI] [PubMed] [Google Scholar]
  • [47].Mallikarjuna K, Nishanth K, Reddy KS. Hepatic glutathione mediated antioxidant system in ethanol treated rats: Decline with age. Pathophysiology. 2006 doi: 10.1016/j.pathophys.2006.09.005., Epub ahead of print.
  • [48].Kallama S, Hemminki K. Urinary excretion products after the administration of 14C-acetaldehyde to rats. J Appl Toxicol. 1983;3:313–6. doi: 10.1002/jat.2550030608. [DOI] [PubMed] [Google Scholar]
  • [49].Hemminki K. Urinary sulfur containing metabolites after administration of ethanol, acetaldehyde and formaldehyde to rats. Toxicol Lett. 1982;11:1–6. doi: 10.1016/0378-4274(82)90096-0. [DOI] [PubMed] [Google Scholar]
  • [50].Kera Y, Kiriyama T, Komura S. Conjugation of acetaldehyde with cysteinylglycine, the first metabolite in glutathione breakdown by gammaglutamyltranspeptidase. Agents Actions. 1985;17:48–52. doi: 10.1007/BF01966681. [DOI] [PubMed] [Google Scholar]
  • [51].Uysal M, Aykae G, Koeak-Toker N, Sivas A, Oz H. The in vitro conjugation of acetaldehyde with glutathione, cysteine and mercaptopropionylglycine. IRCS Med Sci. 1985;11:879. [Google Scholar]
  • [52].Speisky H, Kera Y, Penttila KE, Israel Y, Lindros KO. Depletion of hepatic glutathione by ethanol occurs independently of ethanol metabolism. Alcohol Clin Exp Res. 1988;12:224–8. doi: 10.1111/j.1530-0277.1988.tb00184.x. [DOI] [PubMed] [Google Scholar]
  • [53].Pierson JL, Mitchell MC. Increased hepatic efflux of glutathione after chronic ethanol feeding. Biochem Pharmacol. 1986;35:1533–7. doi: 10.1016/0006-2952(86)90121-8. [DOI] [PubMed] [Google Scholar]
  • [54].Luczaj W, Waszkiewicz E, Skrzydlewska E, Roszkowska-Jakimiec W. Green tea protection against age-dependent ethanol-induced oxidative stress. J Toxicol Environ Health A. 2004;67:595–606. doi: 10.1080/15287390490425579. [DOI] [PubMed] [Google Scholar]
  • [55].Nordmann R, Ribiere C, Rouach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic Biol Med. 1992;12:219–40. doi: 10.1016/0891-5849(92)90030-k. [DOI] [PubMed] [Google Scholar]
  • [56].Shaw S. Lipid peroxidation, iron mobilization and radical generation induced by alcohol. Free Radic Biol Med. 1989;7:541–7. doi: 10.1016/0891-5849(89)90030-0. [DOI] [PubMed] [Google Scholar]
  • [57].Knecht KT, Bradford BU, Mason RP, Thurman RG. In vivo formation of a free radical metabolite of ethanol. Mol Pharmacol. 1990;38:26–30. [PubMed] [Google Scholar]
  • [58].Reinke LA, Kotake Y, McCay PB, Janzen EG. Spin-trapping studies of hepatic free radicals formed following the acute administration of ethanol to rats: in vivo detection of 1-hydroxyethyl radicals with PBN. Free Radic Biol Med. 1991;11:31–9. doi: 10.1016/0891-5849(91)90185-6. [DOI] [PubMed] [Google Scholar]
  • [59].Loguercio C, Clot P, Albano E, Argenzio F, Grella A, De Girolamo V, et al. Free radicals and not acetaldehyde influence the circulating levels of glutathione after acute or chronic alcohol abuse: in vivo and in vitro studies. Ital J Gastroenterol Hepatol. 1997;29:168–73. [PubMed] [Google Scholar]
  • [60].McIntyre TM, Curthoys NP. The interorgan metabolism of glutathione. Int J Biochem. 1980;12:545–51. doi: 10.1016/0020-711x(80)90005-1. [DOI] [PubMed] [Google Scholar]
  • [61].Slusser SO, Grotyohann LW, Martin LF, Scaduto RC., Jr. Glutathione catabolism by the ischemic rat kidney. Am J Physiol. 1990;258:F1546–53. doi: 10.1152/ajprenal.1990.258.6.F1547. [DOI] [PubMed] [Google Scholar]
  • [62].Bump EA, al-Sarraf R, Pierce SM, Coleman CN. Elevation of mouse kidney thiol content following administration of glutathione. Radiother Oncol. 1992;23:21–5. doi: 10.1016/0167-8140(92)90301-a. [DOI] [PubMed] [Google Scholar]
  • [63].Aebi S, Lauterburg BH. Divergent effects of intravenous GSH and cysteine on renal and hepatic GSH. Am J Physiol. 1992;263:R348–52. doi: 10.1152/ajpregu.1992.263.2.R348. [DOI] [PubMed] [Google Scholar]
  • [64].Richie JP, Jr., Lang CA. The determination of glutathione, cyst(e)ine, and other thiols and disulfides in biological samples using high-performance liquid chromatography with dual electrochemical detection. Anal Biochem. 1987;163:9–15. doi: 10.1016/0003-2697(87)90085-6. [DOI] [PubMed] [Google Scholar]
  • [65].Lauterburg BH, Mitchell JR. Regulation of hepatic glutathione turnover in rats in vivo and evidence for kinetic homogeneity of the hepatic glutathione pool. J Clin Invest. 1981;67:1415–24. doi: 10.1172/JCI110170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [66].Lauterburg BH, Adams JD, Mitchell JR. Hepatic glutathione homeostasis in the rat: efflux accounts for glutathione turnover. Hepatology. 1984;4:586–90. doi: 10.1002/hep.1840040402. [DOI] [PubMed] [Google Scholar]
  • [67].Higashi T, Tateishi N, Sakamoto Y. Liver glutathione as a reservoir of L-cysteine. Prog Clin Biol Res. 1983;125:419–34. [PubMed] [Google Scholar]
  • [68].Hidalgo J, Garvey JS, Armario A. On the metallothionein, glutathione and cysteine relationship in rat liver. J Pharmacol Exp Ther. 1990;255:554–64. [PubMed] [Google Scholar]
  • [69].Kershaw WC, Iga T, Klaassen CD. Ethanol decreases cadmium hepatotoxicity in rats: possible role of hepatic metallothionein induction. Toxicol Appl Pharmacol. 1990;106:448–55. doi: 10.1016/0041-008x(90)90339-v. [DOI] [PubMed] [Google Scholar]
  • [70].Kershaw WC, Lehman-McKeeman LD, Klaassen CD. Hepatic isometallothioneins in mice: induction in adults and postnatal ontogeny. Toxicol Appl Pharmacol. 1990;104:267–75. doi: 10.1016/0041-008x(90)90301-a. [DOI] [PubMed] [Google Scholar]
  • [71].Li GC. Induction of thermotolerance and enhanced heat shock protein synthesis in Chinese hamster fibroblasts by sodium arsenite and by ethanol. J Cell Physiol. 1983;115:116–22. doi: 10.1002/jcp.1041150203. [DOI] [PubMed] [Google Scholar]
  • [72].Plesset J, Palm C, McLaughlin CS. Induction of heat shock proteins and thermotolerance by ethanol in Saccharomyces cerevisiae. Biochem Biophys Res Commun. 1982;108:1340–5. doi: 10.1016/0006-291x(82)92147-7. [DOI] [PubMed] [Google Scholar]
  • [73].Liu AY, Lin Z, Choi HS, Sorhage F, Li B. Attenuated induction of heat shock gene expression in aging diploid fibroblasts. J Biol Chem. 1989;264:12037–45. [PubMed] [Google Scholar]
  • [74].Fargnoli J, Kunisada T, Fornace AJ, Jr., Schneider EL, Holbrook NJ. Decreased expression of heat shock protein 70 mRNA and protein after heat treatment in cells of aged rats. Proc Natl Acad Sci U S A. 1990;87:846–50. doi: 10.1073/pnas.87.2.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [75].Blake MJ, Udelsman R, Feulner GJ, Norton DD, Holbrook NJ. Stress-induced heat shock protein 70 expression in adrenal cortex: an adrenocorticotropic hormone-sensitive, age-dependent response. Proc Natl Acad Sci U S A. 1991;88:9873–7. doi: 10.1073/pnas.88.21.9873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [76].Lauterburg BH, Davies S, Mitchell JR. Ethanol suppresses hepatic glutathione synthesis in rats in vivo. J Pharmacol Exp Ther. 1984;230:7–11. [PubMed] [Google Scholar]
  • [77].Speisky H, MacDonald A, Giles G, Orrego H, Israel Y. Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration. Turnover studies. Biochem J. 1985;225:565–72. doi: 10.1042/bj2250565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [78].Chen TS, Richie JP, Jr., Lang CA. Life span profiles of glutathione and acetaminophen detoxification. Drug Metab Dispos. 1990;18:882–7. [PubMed] [Google Scholar]
  • [79].Wang CJ, Wang SW, Shiah HS, Lin JK. Effect of ethanol on hepatotoxicity and hepatic DNA-binding of aflatoxin B1 in rats. Biochem Pharmacol. 1990;40:715–21. doi: 10.1016/0006-2952(90)90306-6. [DOI] [PubMed] [Google Scholar]
  • [80].Boyer CS, Petersen DR. Potentiation of cocaine-mediated hepatotoxicity by acute and chronic ethanol. Alcohol Clin Exp Res. 1990;14:28–31. doi: 10.1111/j.1530-0277.1990.tb00441.x. [DOI] [PubMed] [Google Scholar]
  • [81].Ritzmann RF, Springer A. Age differences in brain sensitivity and tolerance to ethanol in mice. Age. 1980;3:15–7. [Google Scholar]
  • [82].Weaver MS, Lee YH, Morris JL, Randall PK, Schallert T, Leslie SW. Effects of in vitro ethanol and fetal ethanol exposure on glutathione stimulation of N-methyl-D-aspartate receptor function. Alcohol Clin Exp Res. 1993;17:643–50. doi: 10.1111/j.1530-0277.1993.tb00812.x. [DOI] [PubMed] [Google Scholar]
  • [83].Leslie SW, Brown LM, Trent RD, Lee YH, Morris JL, Jones TW, et al. Stimulation of N-methyl-D-aspartate receptor-mediated calcium entry into dissociated neurons by reduced and oxidized glutathione. Mol Pharmacol. 1992;41:308–14. [PubMed] [Google Scholar]

RESOURCES